CSI Market
Sign In | Register

Jaguar Health Inc (JAGX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access JAGX Annual Cash Flow →
From Jaguar Health Inc through Jun 30 2025, changes in Jun 30 2026's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-23.80
Depreciation & amortization0.95
Amortization of Other Assets1.37
Increase (Decrease) in Deferred Revenue0.00
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-1.28
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.33
Income (Loss) from Equity Method Investments-0.04
Gains (Losses) on Extinguishment of Debt-4.13
Materials Cost In Connection With License Activity-
Warrants Issued In Connection With Transfer Agreement-
Amortization Of Beneficial Conversion Feature-
Increase Decrease In Prepaid License Fee-
Increase Decrease In Deferred Rent-
Amortization Of Debt Issuance Costs And Debt Discount-
Noncash Merger Related Costs-
Charge In Relation To Modification Of Warrants-
Fair Value Adjustment Of Derivative Liability-
Interest Paid On Conversion Of Debt To Equity-
Common Stock Issued In Exchange Of Services Rendered-
Operating Lease Right Of Use Asset Amortization-
Increase Decrease In Deferred Offering Costs-
Increase Decrease In Deferred Collaboration Revenue-
Increase Decrease In Operating Lease Liabilities-0.05
Business Combination Consideration Common Stock Issued In Relation To Redemption Of Notes Payable And Related Interest-
Debt Conversion Converted Instrument Amount-
Repayment Of Accrued Interest On Note Payable By Issuance Of Common Stock-
Common Stock Issued In Exchange Of Services-
Fair Value Adjustment Of Financial Instruments And Hybrid Instrument Designated At Fair Value Of Option0.34
Operating Lease Right Of Use Asset Amortization Expense0.05
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-1.50
Increase (Decrease) in Accounts Payable-3.89
Increase (Decrease) in Accrued Liabilities0.98
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.09
Other Working Capital-0.03
Other Noncash Income (Expense)0.00
Other net-0.25
Payments for (Proceeds from) Other Operating Activities34.88
Discontinued operations0.00
Net Cash flow from Operating Activities3.49
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase Decrease In Restricted Cash For Investing Activities-
Shares Issued In Exchange Of Notes Payable And Accrued Interest-
Shares Issued In Exchange Of Preferred Stock-
Common Stock Issued From Conversion Of Warrants-
Warrants Issued In Exchange For Preferred Stock1.51
Deemed Dividend Related To Conversion Of Preferred Stock1.51
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments for Advance to Affiliate0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.02
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock1.98
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-6.73
Proceeds From Issuance Secondary Offering-
Business Combination Consideration Transferred Equity Interests Issued And Issuable-
Business Combination Consideration Transferred Common Stock Warrants Issued And Issuable-
Business Combination Consideration Transferred Replacement Restricted Stock Units Issued And Issuable-
Business Combination Consideration Transferred Replacement Stock Options Issued And Issuable-
Proceeds From Issuance Of Common Stock Through Stock Purchase Agreement-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents7.83
Temporary Equity Accretion To Redemption Value Adjustment-
Proceeds From Cost Associated With Issuance Of Common Stock Through Stock Purchase Agreement-
Proceeds From Issuance Of Long Term Debt Excluding Issuance Of Convertible Debt-
Proceeds From Issuance Of Convertible Preferred Stock In Private Investment In Public Entities-
Premiums Receivable Proceeds From Sale Of Receivables-
Proceeds From Sale Of Finance Receivable-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-4.75
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow3.49
Total Cash Flow-1.24
4 historic quarters locked

Sign in to unlock the full Jaguar Health Inc cash flow history.

Sign In Create Free Account

About Jaguar Health Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-356570

Figures are derived from filed reports and may be restated. Historical data is subject to revision.